Effects of pioglitazone on the transdifferentiation and CTGF expression of renal tubular epithelial-myofibroblast in vitro

Journal of Sichuan University (Medical Science)

Volumn 41, Issue 1, 2010, Pages 15-19

  Pu, Lei ^a   Fan, Jun Ming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Pioglitazone; Transdifferentiation; Transforming growth factor

Indexed keywords

EID: 76249120863     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. ODonnell MP. Renal tubulointerstitial fibrosis. New thoughts on its development and progression. Postgrad Med, 2000, 108 (1), 159-162, 165, 171-172.
2. Fan JM, Ng YY, HiIl PA, et al. Transforming growth factorbeta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int, 1999, 56(4), 1455-1467.
3. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol, 2001, 159(4), 1465-1475. (Pubitemid 32947976)
4. Fan JM, Huang XR, Ng YY, et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-betal-dependent mechanism in vitro. Am J Kidney Dis, 2001, 37(4), 820-831.
5. Galli A, Crabb DW, Ceni E, et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology, 2002, 122 (7), 1924-1940. (Pubitemid 34651436)
6. Tetsuya S, Hiroyuki T, Shunji H, et al. Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation, 2002, 106(24), 3126-3132. (Pubitemid 35440299)
7. Shinzato T, Ohya Y, Nakamoto M, et al. Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Hypertens Res, 2007, 30(9), 863-873. (Pubitemid 47578249)
8. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ, 1996, 7(4), 469-480. (Pubitemid 26362091)
9. Riser BL, Denichilo M, Cortes P, et al. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis. J Am Soc Nephrol, 2000, 11(1), 25-38. (Pubitemid 30020423)
10. Asano T, Wakisaka M, Yoshinari M, et al. Peroxisome proliferator- activated receptor gammal (PPARgammal) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. Biochim Biophys Acta, 2000, 1497 (1), 148-154. (Pubitemid 30330899)
11. Yokoi H, Mukoyama M, Sugawara A, et al. Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis. Am J Physiol Renal Physiol, 2002, 282(5), F933-F942. (Pubitemid 34654499)
12. Zhang C, Meng X, Zhu Z, et al. Connective tissue growth factor regulates the key events in tubular epithelial to myofibroblast transition in vitro. Cell Biol Int, 2004, 28(12), 863-873. (Pubitemid 39573513)
13. Yokoi H, Sugawara A, Mukoyama M, et al. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta, a potential target for preventing renal fibrosis. Am J Kidney Dis, 2001, 38(4 Suppl l), S134-S138. (Pubitemid 32927628)
14. Gore-Hyer E, Shegogue D, Markiewicz M, et al. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am J Physiol Renal Physiol, 2002, 283(4), F707-F716. (Pubitemid 35033958)
15. Maeda A, Horikoshi S, Gohda T, et al. Pioglitazone attenuates TGF-beta(l)-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferato-activated receptor (PPAR) gamma. Cell Biol Int, 2005, 29(6), 422-428. (Pubitemid 41073640)